Skip to main content

YI · 111, Inc. · Financials

Track YI — free
$2.51 -0.28 (-9.99%) At close · Nov 19 Q4 2024 earnings call transcript
Market Cap
$22.08M
Shares
8.80M
Volume · Nov 19 10.2K Avg daily vol (3M) 15.76K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
12.56B -12.8%
FY2025 Revenue FY2016–FY2025
Net Income
-499.61M -30.8%
FY2019 Net Income FY2016–FY2019
Gross Margin
5.76% 0pp
FY2025 Gross Margin FY2016–FY2025
Operating Margin
-0.02% 0pp
FY2025 Operating Margin FY2016–FY2025
Diluted EPS
-0.38 0%
FY2025 Diluted EPS FY2019–FY2025
Operating Cash Flow
119.14M -54.7%
FY2025 Operating Cash Flow FY2016–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016
CNY 12.56B 14.4B 14.95B 13.52B 12.43B 8.2B 3.95B 1.79B 959.49M 873.84M
CNY 11.83B 13.57B 14.1B 12.68B 11.8B 7.84B 3.79B 73.93M 55.88M —
CNY 723.41M 829.23M 848.98M 839.98M 621.1M 365.83M 165.18M 104.27M 80.5M 74.13M
CNY 258.64M 313.9M 448.39M 457.88M 513.15M 399.61M 340.56M 260.04M 190.07M 252.83M
CNY 69.46M 70.91M 224.2M 205.62M 206.98M 128.23M 123.5M 98.76M 53.43M 60.84M
CNY 568K 815K 1.01M 1.74M 1.71M 1.79M — 623K 617K 698K
CNY 11.84M 16.97M 21.78M 40.82M 27.22M 14.02M 11.67M 11.27M 14.82M 12.06M
CNY 12.56B 14.4B 15.3B 13.89B 13.07B 8.68B 4.45B 2.19B 1.21B 1.24B
CNY -2.38M 2.11M -350.1M -371M -642.14M -473.31M -493.51M -400.38M -254.02M -364.28M
CNY 35.57M 28.33M 20.14M 13.44M 5.49M 8.82M 3.62M — 55K 751K
CNY 3.89M 7.04M 8.83M 8.12M 9.78M 6.31M 4.8M 4.35M 4.01M 2.31M
CNY 11.08M -595K 7.61M 8.13M 14.89M 3.16M 834K 11.53M 4.23M -3.35M
CNY -22.5M -20.68M -353.18M -376.07M -621.03M -467.11M -501.83M -382.03M -249.33M -363.45M
CNY 13K 96K 251K 0 0 0 0 8000 — —
CNY -22.52M -20.78M -353.43M -376.07M -621.03M -467.11M -501.83M -382.04M -249.33M -363.45M
CNY -4.09M -8.4M -16.83M -15.28M -27.82M 0 -2.22M -1.95M -747K -765K
CNY -66.39M -64.74M -392.69M -416.88M -669.81M -456.53M -499.61M -380.09M -248.58M -417.96M
CNY -68.11M -62.9M -395.77M -400.66M -673.35M -470.06M -490.24M -360.57M -265.9M -376.72M
USD/shares -$0.05 -$0.05 -$0.33 -$0.36 -$0.63 — — — — —
USD/shares -$0.05 -$0.05 -$0.33 -$0.36 -$0.63 — — — — —
shares 174.03M 171.84M 168.61M 166.63M 165.87M 164.79M 163.67M 99.45M 72M 72M
shares 174.03M 171.84M 168.61M 166.63M 165.87M 164.79M 163.67M 99.45M 72M 72M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2019–FY2021: 40.86M in buybacks.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Noncurrent operating lease liabilities 2025-12-31 USD 4,285,000 20-F filed 2026-04-30
Operating lease liabilities 2025-12-31 CNY 49,082,000 20-F filed 2026-04-30
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current operating lease liabilities
CNY 19,117,000
Noncurrent operating lease liabilities
CNY 29,965,000
Short-term borrowings 2025-12-31 CNY 187,631,000 20-F filed 2026-04-30
Short-term borrowings 2025-12-31 USD 26,831,000 20-F filed 2026-04-30
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
—
Peer median 1.04×
EV/EBIT
—
P/E (TTM)
—
Price/Sales (TTM)
—
Peer median 0.37×
Price/Book
—

Peer medians compare against the 4 similar-size Medical Distribution companies (of 12 listed).

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (CNY)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Business to Business B2b Business 12,321,205,000 14,123,152,000 14,570,766,000 13,075,170,000 11,839,850,000 7,490,449,000 3,293,268,000 1,061,559,000
Business to Consumer B2c Business 234,818,000 278,097,000 377,363,000 441,528,000 491,855,000 666,223,000 636,430,000 709,585,000

By Product & Service (CNY)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Drugs 11,649,921,000 13,398,162,000 13,883,055,000 12,572,634,000 11,681,106,000 7,398,433,000 3,595,419,000 1,490,834,000
Nutritional Supplements 434,685,000 550,464,000 631,122,000 554,789,000 442,497,000 — 245,644,000 190,425,000
Business to Consumer B2c Business 223,217,000 — — — 491,855,000 666,223,000 — 709,585,000
Medical Supplies and Devices 152,351,000 144,282,000 157,504,000 164,916,000 124,919,000 — 50,178,000 26,563,000
Mp Service 56,749,000 — — — 52,309,000 30,533,000 17,239,000 12,490,000
Service — — — 113,262,000 94,197,000 — — 14,826,000
Service Other — 40,973,000 35,948,000 44,785,000 41,888,000 15,952,000 — 2,336,000
Business to Business B2b Business — — — — 11,839,850,000 — — 1,061,559,000
Contact Lenses — — — — 38,000 3,420,000 18,110,000 47,295,000
Other Products — 201,832,000 170,229,000 — 83,183,000 49,949,000 20,347,000 16,027,000
Key facts CIK 1738906 CUSIP 68247Q201 13F (30d) 11 filings 11 filers Visit website Investor relations